S 1407 · in committee · significant
ABC Safe Drug Act
- healthcare
What this bill does
- The bill prohibits federal health care programs from purchasing drugs with active ingredients made in China by 2030.
- Federal agencies, drug manufacturers, and companies in the pharmaceutical supply chain are affected by the restrictions and labeling requirements.
- The bill offers 100% tax deductions for pharmaceutical manufacturing equipment purchases from 2025 to 2030 to incentivize domestic production.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would the 2030 deadline for eliminating Chinese-made drug ingredients affect patients who rely on medications that currently depend on Chinese supply chains?
- 02
What evidence suggests that tax deductions for manufacturing equipment will successfully shift pharmaceutical production to the United States within five years?
- 03
Which federal health care programs would face the largest costs or disruptions from sourcing only domestically-made active ingredients?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-AR
Tom Cotton
Citizen cosponsors
0
In Congress
0/ 100
Senators cosponsoring
Introduced 2025-04-10
Legislative timeline
2025-04-10 · senate · IntroReferral
Read twice and referred to the Committee on Finance.
2025-04-10 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.